Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Aarey Drugs & Pharmaceuticals Ltd. is currently lagging behind its peers in all major financial metrics, indicating a challenging position in the Pharmaceuticals & Drugs sector. While other companies exhibit strong growth and profitability, Aarey demonstrates no revenue growth, zero profitability metrics, and a significant valuation multiple. This highlights an opportunity for improvement or a strategic pivot to enhance its market standing.
Strong revenue growth of 8.42% YoY and a high ROE of 16.13%.
Best in class with the highest ROE (21.76%) and a strong EPS growth.
Exceptional revenue growth of 18.12% YoY and solid profitability metrics.